Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$18.00 | Hmpgfs | Hrsdtpqt |
Narrow-Moat Bio-Techne Still Benefiting From COVID Tailwinds; Long-Term Growth Drivers Intact
Business Strategy and Outlook
Bio-Techne is a market leader in proteins for the pharma, biotech, academic, and diagnostic markets and maintains strong market positioning in antibodies and testing controls for diagnostic partners.